| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Helix BioPharma Corp (TO: HBP)
HBP Technical Analysis
5
| As on 14th Aug 2025 HBP STOCK Price closed @ 1.22 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.35 & Strong Buy for SHORT-TERM with Stoploss of 0.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HBPSTOCK Price
| Open | 1.12 | Change | Price | % |
| High | 1.22 | 1 Day | 0.10 | 8.93 |
| Low | 1.12 | 1 Week | 0.14 | 12.96 |
| Close | 1.22 | 1 Month | 0.32 | 35.56 |
| Volume | 8401 | 1 Year | 1.02 | 510.00 |
| 52 Week High 1.34 | 52 Week Low 0.17 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| UEX | 0.50 | 16.28% |
| WEED | 2.06 | -9.25% |
| TLRY | 1.63 | -5.23% |
| EQX | 10.80 | 15.14% |
| MFC | 42.25 | 0.69% |
| SJR-B | 40.48 | 0.02% |
| CNQ | 41.15 | -0.12% |
| CVE | 20.91 | 0.92% |
| CXB | 2.99 | -0.33% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| HBP Daily Charts |
HBP Intraday Charts |
Whats New @ Bazaartrend |
HBP Free Analysis |
|
|
HBP Important Levels Intraday
| RESISTANCE | 1.41 |
| RESISTANCE | 1.35 |
| RESISTANCE | 1.31 |
| RESISTANCE | 1.27 |
| SUPPORT | 1.17 |
| SUPPORT | 1.13 |
| SUPPORT | 1.09 |
| SUPPORT | 1.03 |
HBP Forecast August 2025
| 4th UP Forecast | 1.28 |
| 3rd UP Forecast | 1.26 |
| 2nd UP Forecast | 1.25 |
| 1st UP Forecast | 1.24 |
| 1st DOWN Forecast | 1.2 |
| 2nd DOWN Forecast | 1.19 |
| 3rd DOWN Forecast | 1.18 |
| 4th DOWN Forecast | 1.16 |
HBP Weekly Forecast
| 4th UP Forecast | 1.34 |
| 3rd UP Forecast | 1.30 |
| 2nd UP Forecast | 1.28 |
| 1st UP Forecast | 1.25 |
| 1st DOWN Forecast | 1.19 |
| 2nd DOWN Forecast | 1.16 |
| 3rd DOWN Forecast | 1.14 |
| 4th DOWN Forecast | 1.10 |
HBP Forecast2025
| 4th UP Forecast | 3.49 |
| 3rd UP Forecast | 2.76 |
| 2nd UP Forecast | 2.31 |
| 1st UP Forecast | 1.86 |
| 1st DOWN Forecast | 0.58 |
| 2nd DOWN Forecast | 0.13 |
| 3rd DOWN Forecast | -0.32 |
| 4th DOWN Forecast | -1.05 |
Helix BioPharma Corp ( TO Canada Symbol : HBP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HBP Business Profile
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada. Address: 9120 Leslie Street, Richmond Hill, ON, Canada, L4B 3J9
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service